Suppr超能文献

巨噬细胞迁移抑制因子/CD74和RTL1000/CD74复合物的预测结构。

Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.

作者信息

Meza-Romero Roberto, Benedek Gil, Leng Lin, Bucala Richard, Vandenbark Arthur A

机构信息

Neuroimmunology Research, VA Portland Health Care System, 3710 SW US Veterans Hosp. Rd, Portland, OR, 97239, USA.

Tykeson MS Research Laboratory, Department of Neurology UHS-46, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, USA.

出版信息

Metab Brain Dis. 2016 Apr;31(2):249-55. doi: 10.1007/s11011-016-9798-x. Epub 2016 Feb 6.

Abstract

Macrophage migration inhibitory factor (MIF) is a key cytokine in autoimmune and inflammatory diseases that attracts and then retains activated immune cells from the periphery to the tissues. MIF exists as a homotrimer and its effects are mediated through its primary receptor, CD74 (the class II invariant chain that exhibits a highly structured trimerization domain), present on class II expressing cells. Although a number of binding residues have been identified between MIF and CD74 trimers, their spatial orientation has not been established. Using a docking program in silico, we have modeled binding interactions between CD74 and MIF as well as CD74 and a competitive MIF inhibitor, RTL1000, a partial MHC class II construct that is currently in clinical trials for multiple sclerosis. These analyses revealed 3 binding sites on the MIF trimer that each were predicted to bind one CD74 trimer through interactions with two distinct 5 amino acid determinants. Surprisingly, predicted binding of one CD74 trimer to a single RTL1000 antagonist utilized the same two 5 residue determinants, providing strong suggestive evidence in support of the MIF binding regions on CD74. Taken together, our structural modeling predicts a new MIF(CD74)3 dodecamer that may provide the basis for increased MIF potency and the requirement for ~3-fold excess RTL1000 to achieve full antagonism.

摘要

巨噬细胞移动抑制因子(MIF)是自身免疫性疾病和炎症性疾病中的一种关键细胞因子,它能吸引外周的活化免疫细胞并使其滞留于组织中。MIF以同三聚体形式存在,其作用通过其主要受体CD74(II类恒定链,具有高度结构化的三聚化结构域)介导,该受体存在于表达II类分子的细胞上。尽管已经确定了MIF与CD74三聚体之间的一些结合残基,但它们的空间取向尚未明确。我们利用计算机对接程序,对CD74与MIF以及CD74与一种竞争性MIF抑制剂RTL1000(一种部分MHC II类构建体,目前正处于多发性硬化症的临床试验阶段)之间的结合相互作用进行了建模。这些分析揭示了MIF三聚体上的3个结合位点,预计每个位点通过与两个不同的5个氨基酸决定簇相互作用结合一个CD74三聚体。令人惊讶的是,预测一个CD74三聚体与单个RTL1000拮抗剂的结合利用了相同的两个5个残基决定簇,为CD74上的MIF结合区域提供了有力的支持证据。综上所述,我们的结构建模预测了一种新的MIF(CD74)3十二聚体,它可能为提高MIF效力以及需要约3倍过量的RTL1000才能实现完全拮抗作用提供基础。

相似文献

1
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Metab Brain Dis. 2016 Apr;31(2):249-55. doi: 10.1007/s11011-016-9798-x. Epub 2016 Feb 6.
2
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Cytokine. 2016 Dec;88:62-70. doi: 10.1016/j.cyto.2016.08.024. Epub 2016 Aug 27.
3
Nanosecond Dynamics Regulate the MIF-Induced Activity of CD74.
Angew Chem Int Ed Engl. 2018 Jun 11;57(24):7116-7119. doi: 10.1002/anie.201803191. Epub 2018 May 9.
4
MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations.
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10994-9. doi: 10.1073/pnas.1221817110. Epub 2013 Jun 17.
5
An Analysis of MIF Structural Features that Control Functional Activation of CD74.
Chem Biol. 2015 Sep 17;22(9):1197-205. doi: 10.1016/j.chembiol.2015.08.006. Epub 2015 Sep 10.
6
A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).
J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.
7
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Cell Signal. 2018 Jun;46:32-42. doi: 10.1016/j.cellsig.2018.02.010. Epub 2018 Feb 21.
8
Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
Clin Orthop Relat Res. 2014 Jun;472(6):1943-54. doi: 10.1007/s11999-014-3508-y. Epub 2014 Feb 26.

引用本文的文献

4
Crystal structure of N-terminally hexahistidine-tagged Onchocerca volvulus macrophage migration inhibitory factor-1.
Acta Crystallogr F Struct Biol Commun. 2024 Dec 1;80(Pt 12):328-34. doi: 10.1107/S2053230X24010550.
7
The role of CD74 in cardiovascular disease.
Front Cardiovasc Med. 2023 Jan 12;9:1049143. doi: 10.3389/fcvm.2022.1049143. eCollection 2022.
8
Hallmarks of Cancer Affected by the MIF Cytokine Family.
Cancers (Basel). 2023 Jan 6;15(2):395. doi: 10.3390/cancers15020395.
9
Review of potential medical treatments for middle ear cholesteatoma.
Cell Commun Signal. 2022 Sep 19;20(1):148. doi: 10.1186/s12964-022-00953-w.

本文引用的文献

1
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages.
Front Immunol. 2015 Dec 24;6:647. doi: 10.3389/fimmu.2015.00647. eCollection 2015.
2
An Analysis of MIF Structural Features that Control Functional Activation of CD74.
Chem Biol. 2015 Sep 17;22(9):1197-205. doi: 10.1016/j.chembiol.2015.08.006. Epub 2015 Sep 10.
3
MIF and CD74 - suitability as clinical biomarkers.
Mini Rev Med Chem. 2014;14(14):1125-31. doi: 10.2174/1389557515666150203143317.
4
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
J Immunol. 2014 May 1;192(9):4164-73. doi: 10.4049/jimmunol.1303118. Epub 2014 Mar 28.
5
ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers.
Bioinformatics. 2014 Jun 15;30(12):1771-3. doi: 10.1093/bioinformatics/btu097. Epub 2014 Feb 14.
6
Immunology of relapse and remission in multiple sclerosis.
Annu Rev Immunol. 2014;32:257-81. doi: 10.1146/annurev-immunol-032713-120227. Epub 2014 Jan 15.
7
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
J Immunol. 2013 Aug 1;191(3):1043-54. doi: 10.4049/jimmunol.1200485. Epub 2013 Jun 24.
8
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Eur J Immunol. 2013 May;43(5):1309-21. doi: 10.1002/eji.201243162. Epub 2013 Apr 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验